PLUS1 study
Phase 3
- Conditions
- Thrombocytopenia due to chronic liver disease
- Registration Number
- JPRN-jRCT2080222274
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Main inclusion criteria:
Thrombocytopenic patients with chronic liver disease undergoing invasive procedures.
Exclusion Criteria
Main exclusion criteria:
Patients who received blood transfusions (except for red blood cell products and albumin preparations) within 14 days prior to enrollment.
Patients who previously received TPO receptor agonists.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, safety
- Secondary Outcome Measures
Name Time Method